The Favorskii rearrangement is an important chemical transformation that usually occurs for α-haloketones to form carboxylic acids and their derivatives under alkaline conditions. During the stability study of a clobetasol propionate topical solution, it has been found that clobetasol propionate, a corticosteroid possessing the 20-ketone-21chloro moiety in the 17-position of the D ring, forms a major degradant via a Favorskii-like rearrangement under weakly acidic conditions. The mechanism of this variation of the original Favorskii rearrangement is proposed and the activation energy
for the formation of the degradant is calculated.
Introduction
The Favorskii rearrangement is an important chemical reaction discovered in 1894 1 , which describes the transformation of α-haloketones to carboxylic acids, esters and amides under the alkaline conditions such as hydroxide, alkoxide ions, ammonia and amines, respectively 2 . Two predominant mechanisms for the Favorskii rearrangement have been proposed based on various mechanistic studies 3 . One is the cyclopropanone mechanism, which involves the open 1,3-dipolar form of cyclopropanone and/or the cyclopropanone as the critical reaction intermediates when an α-hydrogen is present (Scheme 1, Pathway a). The second one is the semi-benzylic mechanism for haloketones without α-hydrogen (Scheme 1, Pathway b), which is also referred as quasi-Favorskii rearrangement 4 . Both mechanisms are operative under alkaline conditions. Various derivatives of carboxylic acids containing the same number of carbon as in the initial ketone can be obtained dependent upon the base and/or solvent used as well as the number of halogen present in the ketone 5, 6 .
During our recent stability studies (Table 1 ) of a formulated 0.05% topical solution of clobetasol propionate (1), a corticosteroidal drug clinically used for the treatment of dermatological diseases 7 , a major degradant (2) was observed under acidic conditions at a level up to 1.39% by using the related substances method (refer to Supplementary data), which exceeded the ICH identification threshold for finished dosage forms. We then identified this major degradant, which eluted at a relative retention time of 0.49 versus clobetasol propionate, using the strategy of LC-PDA/UV-MS n analysis in conjunction with mechanism-based forced degradation and NMR spectroscopy (refer to Supplementary data) [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Upon search in the literature, it indicated that this impurity is listed as Impurity F in the European Pharmacopeia (EP). Nevertheless, this impurity has not been reported in the literature, other than its listing in the EP. Thus, it would be worthwhile to study its formation mechanism in order to control its content in our final formulation of the topic solution of clobetasol propionate. In this paper, we propose a formation mechanism of this degradation impurity from clobetasol propionate under weakly acidic conditions (Scheme 2), which is a variation of the original Favorskii rearrangement that only proceeds under alkaline conditions. The proposed mechanism is based on the evidence obtained from the mechanistic studies involving various forced degradation experiments. Understanding the root cause of degradant formation via mechanistic study would be critical in controlling impurities in drug products, thus ensuring the quality and safety of the drug products 14 .
Initial forced degradation study
Forced degradation on clobetasol propionate was conducted ( Table 2) to investigate the formation mechanism of the degradant at RRT 0.49. Approximately 5 mg of clobetasol propionate was dissolved in a mixture of alcohol/H 2 O (40/60, v/v) and subject to weak acid (acetic acid), strong acid (HCl) and alkaline (NaOH) conditions, respectively. The results show that RRT 0.49 impurity was the major degradation product formed (1.62%), when clobetasol propionate was dissolved in the isopropanol/water mixture in the presence of acetic acid at 60°C for 14 days (Fig. 2) .
On the contrary, under either the alkaline condition (10 mM NaOH, 3 mL) at room temperature for 2 h or strong acidic condition (1 M HCl, 3mL) at 80℃ for 4 h, appreciable decomposition of clobetasol propionate was observed in both cases: the total degradants formed were 6.3% in the alkaline solution and 5.4% in the acidic solution, respectively. Nevertheless, no RRT 0.49 impurity was detected in either of the forced degradation solutions.
Based on the above forced degradation experiments, a solution containing clobetasol propionate (5.0 g), isopropanol (200 mL), water (50 mL) and acetic acid (0.33 mL) was heated at 80℃ for 10 days, during which time RRT 0.49 impurity grew to 2.7%. The impurity was isolated from a portion of the forced degradation sample solution by semi-preparative HPLC (20 mg, HPLC purity ~96%) and subject to 1D and 2D NMR structure elucidation. The structure of RRT 0.49 impurity was identified to be (11β,16β)-9-fluoro-11-hydroxy-16-methyl-3-oxopregna-1,4,17-triene-21-oic acid (2, Fig. 1 ) based on the LC-PDA/UV-MS n and NMR results (refer to Supplementary data). Upon search in the literature, it indicated that the formation mechanism of this impurity has not been reported. Thus, it would be worthwhile to study its formation mechanism in order to control its content in our final formulation of the topic solution of clobetasol propionate.
The formation of RRT 0.49 impurity seems to correlate with the use of acetic acid as it provides a weakly acidic condition (the pKa of acetic acid is 4.8) 18 . When acetic acid was replaced by phosphate buffer and the pH of the resulting solution was adjusted to ~4.6 with phosphoric acid, a similar amount of RRT 0.49 impurity was formed in the clobetasol solution, indicating a weakly acidic condition can facilitate the formation of RRT 0.49 impurity. In addition, the same degradation reaction occurred when isopropanol was replaced by methanol, while the pH remained the same. Hence, it is clear that RRT 0.49 impurity is formed when a solution of clobetasol propionate in a mixture of alcohol (isopropanol or methanol) and water is subject to a weakly acidic condition under elevated temperature. 
Second stage of forced degradation for mechanism study
Based on the above proposed mechanism, it would be difficult for clobetasol, the parent compound of clobetasol propionate, to undergo the same transformation to produce RRT 0.49 impurity, because clobetasol lacks a good leaving group such as the propionyl group at the 17-position. To test this projection based on the proposed mechanism, clobetasol (3) was subject to the same weakly acidic forced degradation condition; indeed, no RRT 0.49 impurity was formed, which is consistent with the projection. It appears that the propionyl group would be a better leaving group than the hydroxyl group within the steroidal core under the weakly acidic condition.
To further study if RRT 0.49 impurity may be formed as a degradant in other corticosteroids that contain an electrophilic group at the 17-position and potential leaving group at the 21-position, betamethasone dipropionate and mometasone furoate were selected and subject to the same forced degradation condition ( Table   2 ). RRT 0.49 impurity was not formed in either of the stressed solutions of betamethasone dipropionate (4) and momentasone furoate (5) . Betamethasone dipropionate 19, 20 is structurally identical to clobetasol propionate, except for the substituent at the 21-position. Hence, with betamethasone dipropionate, its enol form may be less nucleophilic, due to the electron-withdrawing effect of the 21propionyl group, for it to launch the nucleophilic attack to form the critical Favorskii intermediate. With mometasone furoate 21 , its 17-furoyl group may be more difficult to eliminate than the 17-propionyl group (in clobetasol propionate), which may be due to the fact that the ester of an aromatic acid is usually more stable than its counterpart of an aliphatic acid (hence, the linkage between the steroidal core and the 17-furoyl group would be stronger in the case of mometasone furoate). These results are consistent with the proposed mechanism in which the copresence of the 21-chloro-20-ketone and 17-propionyl (an aliphatic acyl) moieties is critical for the formation of RRT 0.49 impurity through the Favorskii-like rearrangement mechanism (Scheme 2).
Kinetic study of RRT 0.49 impurity formation
The growth trend of RRT 0.49 impurity in the finished dosage form of 0.05% solution is found to be linear under the ICH long term, intermediate, and accelerated stability conditions (Table 1) , respectively, which indicates that the formation of RRT 0.49 impurity is a nominal zero order reaction during the ICH stability conditions. Hence, the Arrhenius equation [22] [23] [24] was used to study the kinetic behavior of RRT 0.49 impurity formation in the clobetasol propionate topical solution.
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Where:
k is the rate constant, T is the absolute temperature (in Kelvin), A is the pre-exponential or frequency factor, a constant for each chemical reaction. According to the collision theory, A is the frequency of collisions in the correct orientation, E a is the activation energy for the reaction, R is the universal gas constant.
The E a (activation energy) can be obtained based on the linear plot by using the Arrhenius equation (2). Hence, E a is calculated to be 116.9 kJ·mol -1 (or 28.0 kcal·mol -1 ). The kinetics plot and Arrhenius plot are shown in Supplementary data, Fig. S4 .
Conclusions
A major degradant of clobetasol propionate was observed at RRT 0.49 during the stability studies of a clobetasol propionate topical solution (0.05%, w/v).
Through a comprehensive investigation, a novel mechanism for the formation of 
or αwhich
By applying LC-PDA/UV-MS n analysis in conjunction with mechanism-based forced degradation and NMR spectroscopy, RRT 0.49 impurity was identified to be (11β,16β)-9-fluoro-11-hydroxy-16-methyl-3-oxopregna-1,4,17-triene-21-oic acid, the experimental part and the results are described in Sections 1 to 6 below.
Experimental

Related substances method
The forced degradation samples were analyzed by the related substances method. showed a maximum absorbance band at 240 nm, which is typical for this family of corticosteroids due to the cross-conjugated system in the A-ring of the steroid. On the other hand, the UV spectrum of RRT 0.49 impurity showed a maximum absorbance band at 232 nm, indicating that the two compounds have different chromophores or a new chromophore may be formed in RRT 0.49 impurity (Fig. S1) . (Fig. S2) , suggesting that RRT 0.49 impurity may have similar core structure as clobetasol propionate.
Structure Characterization by 1D and 2D NMR Spectroscopy
After isolation by semi-preparative HPLC, ~20 mg of purified RRT 0.49 impurity was made available for analysis by 1D and 2D NMR spectroscopy. All the 1 H NMR and 13 C NMR data of clobetasol propionate and RRT 0.49 impurity are summarized in indicating that the impurity bears some structural similarity to that of clobetasol propionate. The main difference, nevertheless, exists in their D rings. Specifically, the gHMBC spectrum of the impurity (Fig. S3) respectively, which is consistent with the impurity structure that contains a conjugated enoic acid. 
